A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study - Concepedia

Concepedia

Publication | Open Access

A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study

DOI Full Paper Access

170

Citations

22

References

2016

Year

Dae‐Hyun Yoo, Artur Racewicz, Jan Brzezicki, Roman Yatsyshyn, E. Tobias Arteaga, Asta Baranauskaitė, Carlos Abud‐Mendoza, Sandra Navarra, Vladimir Kadinov, Irmgadt Goecke Sariego,

Arthritis Research & Therapy

Abstract

ClinicalTrials.gov identifier: NCT01217086 . Registered 4 Oct 2010.

References

	Year	Citations

Page 1